SHANGHAI, May 10, 2025 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking abstract presentation on SKG1108, its investigational...
Hence then, the article about skyline therapeutics presents late breaking abstract on skg1108 a novel optogenetic gene therapy for retinitis pigmentosa at asgct 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 )
Also on site :
- French court denies extradition of ex-Tunisian President Ben Ali’s daughter
- Ford and Toyota issue major South African car recall
- ‘Like relying on a drug dealer:’ The world’s dependence on oil and gas has exposed a dangerous vulnerability